The Quest for Off-the-Shelf CAR T Cells [News in Depth]

To improve patient access, companies are exploring this therapy in allogeneic form, but challenges remain.

from Cancer via ola Kala on Inoreader https://ift.tt/2KTfGlx
via IFTTT